Source | M.W. | 421.3 | CAS No. | 879085-55-9 | |
---|---|---|---|---|---|
Structural Info | C19H14Cl2N2O3S | ||||
Formulation | Powder | ||||
Reconstitution | Before reconstitution, werecommend a brief spin to drive down any material dislodged from the bottom ofthe tube. The compound is soluble inDMSO. | ||||
Stability | The powder is stable for at least 2 yearif stored at -20 °C. Thedissolved compound is stable for at least 1 month at 4 °C, but shouldbe stored in aliquots at -20 °C for longer term. Protect from light. | ||||
Purity | Greater than 99% as determined by LC/MS analysis. LC/MS and/or NMR data available upon request. | ||||
Biological Activity | In a cell-based assay measuring the activation of the Gli-1 reporter gene, this compound gives IC50 of 5-20 nM. | ||||
Country of Origin | USA |
GDC-0449 (Vismodegib) ispotent antagonist of SMO (smoothened). This small molecule compound is a hedgehog pathway inhibitor by directlybinding to SMO. This molecule has beendeveloped by Genentech for clinical application against hedgehog-dependentcancers.Ref:Robarge KD, et al. Bioorg Med Chem Lett.Oct 1 2009 19: 5576-81; van Hoff DD, etal. N Engl J Med. Sep 17, 2009 361: 1164-72; Rudin CM et al. N Engl J Med. 2009 Sep 17; 361(12):1173-8.